Associate Director, Market Access, Europe - Basel
vor 3 Tagen
Jobbeschreibung
, consectetur adipiscing elit. Nullam tempor vestibulum ex, eget consequat quam pellentesque vel. Etiam congue sed elit nec elementum. Morbi diam metus, rutrum id eleifend ac, porta in lectus. Sed scelerisque a augue et ornare.
Donec lacinia nisi nec odio ultricies imperdiet.
Morbi a dolor dignissim, tristique enim et, semper lacus. Morbi laoreet sollicitudin justo eget eleifend. Donec felis augue, accumsan in dapibus a, mattis sed ligula.
Vestibulum at aliquet erat. Curabitur rhoncus urna vitae quam suscipit
, at pulvinar turpis lacinia. Mauris magna sem, dignissim finibus fermentum ac, placerat at ex. Pellentesque aliquet, lorem pulvinar mollis ornare, orci turpis fermentum urna, non ullamcorper ligula enim a ante. Duis dolor est, consectetur ut sapien lacinia, tempor condimentum purus.
Zugang zu allen hochrangigen Positionen und den Job Ihrer Träume erhalten.
Ähnliche Jobs
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. The European Market Access Associate Director is responsible to support the strategy and execution of market access activities across European countries. · ...
vor 1 Monat
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. · ...
vor 1 Monat
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. · ...
vor 1 Monat
· Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of R ...
vor 1 Woche
Executive Director, Market Access GI, Europe
Nur für registrierte Mitglieder
Job summaryThe Executive Director Value Market Access Pricing GI will lead the development and execution of European market access and pricing strategies for Revolution Medicines gastrointestinal oncology portfolio. · ...
vor 1 Monat
The Executive Director, Value, Market Access & Pricing (GI) will lead the development and execution of European market access and pricing strategies for Revolution Medicines' gastrointestinal oncology portfolio. · Lead and own the European market access and pricing strategy for G ...
vor 1 Monat
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The Executive Director, Value, Market Access & Pricing (GI) will lead the development and execution of European ...
vor 1 Monat
We seek a dynamic and experienced Senior Marketing Director to play a critical role within the commercial team on the successful launch preparation for future compounds in Lung cancer and beyond. ...
vor 3 Wochen
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS p ...
vor 3 Tagen
The Executive Director, Value and Access for the Direct Report Markets in Region Europe leads and executes the patient access strategy for Novartis portfolio products in a region/country - working strategically and operationally in partnership with Regional TAs, Medical, CE&E · ...
vor 3 Wochen
Senior Director, HEOR, Europe
Nur für registrierte Mitglieder
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS p ...
vor 4 Tagen
Vice President, Communications, Public Affairs and Policy Advocacy, Europe
Nur für registrierte Mitglieder
The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. · Map and assess the evolving oncology policy environment, · Monitor EU legislative p ...
vor 1 Monat
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate in ...
vor 6 Tagen
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. · ...
vor 3 Wochen
Senior Director, Compliance, Europe
Nur für registrierte Mitglieder
We are seeking an experienced compliance leader in Europe to lead our Legal and Compliance function. · This is an excellent opportunity to lead a team and support the launch of new RevMed therapies and the Company's rapid business growth in Europe. · ...
vor 1 Monat
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate in ...
vor 5 Tagen
Senior Director, Compliance, Europe
Nur für registrierte Mitglieder
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS p ...
vor 1 Woche
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS p ...
vor 6 Tagen
Executive Medical Director, GI, Europe
Nur für registrierte Mitglieder
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS p ...
vor 4 Tagen
· Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of R ...
vor 1 Woche